Effect of orlistat and anti-androgen oral contraceptives on pregnancy outcomes in overweight or obese PCOS patients during comprehensive management.

Arch Gynecol Obstet · 2026 · PMC12988960 · PMID 41831044

Europe PMC DOI

hedged sentences

0.0180

closest p · 0.4× alpha

0.0180

boldest claim

The sentences

showed a trendP = 0.018actually significant

The DRSP/EE monotherapy group showed a trend towards reduced GDM risk (χ 2 = 5.552, P = 0.018), but this difference did not reach statistical significance after Bonferroni correction.

also in 53,322 other papers

a decreasing trendno p-value reported

The DRSP/EE monotherapy group (33.3%) showed a decreasing trend, but statistical significance was not maintained after adjustment for multiple comparisons.

also in 47,180 other papers

did not reach statistical significanceno p-value reported

While differences in HDP and other pregnancy outcomes did not reach statistical significance, the combination therapy group yielded the most favorable clinical profile, achieving the numerically highest live birth rate and the lowest incidence of adverse pregnancy outcomes.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.